What do you think about the development of new pharmaceutical medicines?

Please help with this research. It will provide important information on the much needed effective communication of drug development, drug adherence, drug discovery and drug resistance. The theme for this year’s World Health Day was “Antimicrobial resistance: no action today, no cure tomorrow”. It brought to the world’s attention that we are on “the brink of losing our precious arsenal of medicines” that protect and cure us from infections caused by bacteria, fungi, parasites and viruses. Without potentially biasing your answers any further please complete the survey…..

Evenda Dench, a PhD candidate at The University of Western Australia, is conducting a short (10 minute) online survey as part of research investigating attitudes held by the general public towards the development of new pharmaceutical medicines.

Your participation in this survey would be greatly appreciated; simply follow the link below to take part.

The survey can also be accessed at the research group’s homepage at http://www.communicatingscience.org/, or under the menu title > Research.

Your help in forwarding this information to any or all of your personal and professional networks will also increase the number of responses collected, and your support would be sincerely appreciated. The greater the number and diversity of respondents who take part in this survey, the better will be the overall representation of public attitudes about the development of new medicines.

All responses are anonymous, and any individual information collected will remain confidential. This research will not be used for marketing purposes in any way. Following statistical analysis, the results of this survey will be published and made available in 2012 at http://www.communicatingscience.org/.

If you would like more information about this survey or the research project, please contact Evenda Dench at evenda.dench@uwa.edu.au.

Approval to conduct this research has been provided by The University of Western Australia, in accordance with its ethics review and approval procedures (RA/4/1/4786).